Allmed Medical Products Co.,Ltd (SHE:002950)
China flag China · Delayed Price · Currency is CNY
8.54
+0.12 (1.43%)
Sep 30, 2026, 3:04 PM CST

SHE:002950 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
3,8343,6723,3262,7574,2112,926
Revenue Growth
12.07%10.38%20.66%-34.53%43.92%-23.70%
Gross Profit
1,1611,065928.04657.931,399872.17
Operating Income
612.24572.63433.64179.42816.21387.65
Net Income
242.57248.88368.68110.4406.79431.21
Earnings Per Share
0.400.400.590.170.640.68
EPS Growth
-34.73%-31.82%238.44%-72.87%-5.82%-62.73%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Surgery and Wound Care
2,9222,8472,6642,1782,6262,190
Infection Protection
214.4195.48196.9231.111,261433.56
Advanced Dressing
162.45151.55102.5761.5958.230.2
Hygiene and Nursing
258.06189.32170.93130.6999.7266.89
Other
277.01287.84191.57155.23165.68204.71
Total
3,8343,6723,3262,7574,2112,926

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
471.75972.18668.32496786.84686.6
Total Debt
1,221807.57660.7961.06938.131,289
Net Cash (Debt)
-749.74164.617.62-465.06-151.29-602.53
Net Cash Growth
-2060.49%----
Net Cash Per Share
-1.230.270.01-0.73-0.24-0.95

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
331.24717.13711.64423.51,150374.85
Capital Expenditures
-346.28-260.32-157-286.48-398.05-290.7
Free Cash Flow
-15.04456.81554.64137.02751.6884.16
Free Cash Flow Growth
--17.64%304.78%-81.77%793.19%-92.95%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
30.27%29.01%27.90%23.87%33.22%29.81%
Operating Margin
15.97%15.60%13.04%6.51%19.38%13.25%
Pretax Margin
7.66%8.42%13.66%6.13%11.52%17.28%
Profit Margin
6.33%6.78%11.08%4.00%9.66%14.74%
FCF Margin
-0.39%12.44%16.68%4.97%17.85%2.88%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.1460.1460.0600.0270.0600.210
Dividend Per Share Growth
143.33%143.33%122.22%-55.00%-71.43%-76.14%
Dividend Yield
1.71%1.36%0.70%0.29%0.51%1.35%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
21.4927.1514.7054.3819.0724.01
Forward PE
-10.4510.4510.4510.4510.45
P/FCF Ratio
-14.799.7743.8110.32123.03
PS Ratio
1.371.841.632.181.843.54